An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors

NCT02616211 · clinicaltrials.gov ↗

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Adenocarcinoma of Lung
Lung Neoplasm
Cancer of Lung
Lung Cancer
Pulmonary Cancer
EGFR Genes
ALK Genes

Sponsor

Mayo Clinic

Collaborators

[object Object]